The optimization of recombinant antibody production in Chinese Recombinant Antibody hamster ovary (CHO) cells presents a paramount challenge to the biopharmaceutical industry. A variety of strategies are employed maximize antibody titer, such as process parameter optimization, media optimization, and adoption of perfusion systems. Fine-tuning med